Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 4:42 PM
Ignite Modification Date: 2025-12-25 @ 2:30 PM
NCT ID: NCT02433366
Description: Adverse events (AE) were not reported in this trial report but in case a physician or patient mentioned an AE during the interview, the interviewer together with the physician or patient was to complete an AE form which was forwarded to pharmacovigilance unit of BI.
Frequency Threshold: 5
Time Frame: None
Study: NCT02433366
Study Brief: Evaluation the Effectiveness of the Risk Minimisation Activities in the Treatment of Stroke Prevention in Atrial Fibrillation
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Physicians Current prescribers of Pradaxa® for stroke prevention in patients with atrial fibrillation (AF). None None 0 0 0 0 View
Patients AF patients on treatment with Pradaxa®. None None 0 0 0 0 View
Serious Events(If Any):
Other Events(If Any):